Mitsubishi Tanabe Pharma America
Adam Lissa has a diverse and extensive work experience in the pharmaceutical industry. Adam is currently working as the Director of Marketing at Mitsubishi Tanabe Pharma America since 2023. Prior to this, they had a long tenure at Novartis, where they held various roles such as Director-Ophthalmology Value & Access, Director of HCP Marketing-Dermatology, Director of Professional Promotion Dermatology Marketing, Director Professional Promotion Rheumatology Marketing, and Associate Director Oncology- Hematology Franchise. Before joining Novartis, they worked as an Associate Director Respiratory Franchise at Novartis Pharmaceuticals. Adam's career started at Novartis as a Sales Representative/Consultant and gradually progressed to roles like Sales Management, Product Manager, and Senior Product Manager.
Adam Lissa completed their Bachelor of Science degree in Marketing from the University of Delaware, from 1993 to 1997. Adam then pursued further education by earning their Master of Business Administration (MBA) degree in Marketing from Saint Joseph's University - Erivan K. Haub School of Business, studying from 2000 to 2002.
Mitsubishi Tanabe Pharma America
We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life-threatening illnesses. Today, we are focused on driving scientific discovery in many areas. Our focus remains on bringing treatment to people living with ALS as we strive to make a meaningful difference in their lives. Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs. We continue to expand our work to deepen our understanding of ALS, explore potential biomarkers to aid in further research and seek new answers. Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses. Please see our LinkedIn community guidelines here: http://www.mt-pharma-america.com/pdf/LinkedIn-Community-Guidelines.pdf